Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Appropriations Debate Moves To Senate, And From "Hard Science" To Harder Numbers

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency's essentially flat budget clears House, but the absence of a budget resolution in the Senate leaves funding levels for federal agencies in limbo.

You may also be interested in...



FDA’s Funding Outlook Is Relatively Sunny, But Best For Growing Food

The Senate Appropriations Committee on Sept. 7 will vote on an Agriculture/FDA appropriations bill that would increase FDA funding in fiscal 2012 by almost $350 million above levels provided in a House-approved bill (H.R. 2112).

FDA’s Funding Outlook Is Relatively Sunny, But Best For Growing Food

The Senate Appropriations Committee on Sept. 7 will vote on an Agriculture/FDA appropriations bill that would increase FDA funding in fiscal 2012 by almost $350 million above levels provided in a House-approved bill (H.R. 2112).

FDA To Spend PDUFA Reserves To Fund Safety Officers, Personnel Moves

Agency will spend more than 78% of $150.6 million fund by the end of FY 2012 to move CBER to White Oak and pay for new drug safety personnel.

Related Content

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel